Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 83902 refers to a molecular diagnostic procedure known as reverse transcription. This technique involves extracting a molecular sequence from a tissue sample, which is crucial for analyzing genetic material. In reverse transcription, the typical flow of genetic information is reversed; this means that RNA is converted back into DNA. This process is essential for identifying specific sequences of nucleic acids, which can be indicative of genetic mutations associated with various diseases. The ability to detect these mutations is particularly valuable, as it allows for the identification of potential health issues even in the absence of overt symptoms. By utilizing this method, healthcare professionals can gain insights into a patient's genetic makeup, which can inform diagnosis and treatment strategies for conditions that may not yet be clinically apparent.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure associated with CPT® Code 83902 is indicated for various clinical scenarios where genetic analysis is necessary. The following conditions or situations may warrant the use of reverse transcription molecular diagnostics:
The procedure for CPT® Code 83902 involves several critical steps to ensure accurate molecular diagnostics through reverse transcription. Each step is essential for the successful extraction and analysis of genetic material.
Post-procedure care following the molecular diagnostics associated with CPT® Code 83902 typically involves monitoring the patient for any immediate reactions to the tissue sampling process. Additionally, healthcare providers will review the results of the genetic analysis with the patient, discussing any identified mutations and their potential impact on health. Follow-up appointments may be scheduled to further evaluate the patient's condition and to discuss possible treatment options based on the findings. It is also important for healthcare professionals to document the results and any recommendations for further testing or interventions as necessary.
| Short Descr | MOLECULAR DIAGNOSTICS | Medium Descr | MOLECULAR DIAGNOSTICS | Long Descr | Molecular diagnostics; reverse transcription | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Discontinued Code | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
Get instant expert-level medical coding assistance.